IL292946B2
Eribulin-based antibody-drug conjugates and methods of use
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2013130093A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-33 |
| SILAS INMAN, TRASTUZUMAB/ERIBULIN COMBO SAFE AND EFFECTIVE IN HER2-POSITIVE BREAST CANCER, 10 March 2014 (2014-03-10) | Non-patent | – | – | Search report | – |
| NARAYAN, SRIDHAR, ET AL., NOVEL SECOND GENERATION ANALOGS OF ERIBULIN. PART II: ORALLY AVAILABLE AND ACTIVE AGAINST RESISTANT TUMORS IN VIVO., 20 January 2011 (2011-01-20) | Non-patent | – | – | Search report | – |
| ZHANG, NINGYAN, ET AL., TRASTUZUMAB-DOXORUBICIN CONJUGATE PROVIDES ENHANCED ANTI-CANCER POTENCY AND REDUCED CARDIOTOXICITY., 28 February 2013 (2013-02-28) | Non-patent | – | – | Search report | – |
| HU, JIEMIAO, ET AL., HERCEPTIN CONJUGATES LINKED BY EDC BOOST DIRECT TUMOR CELL DEATH VIA PROGRAMMED TUMOR CELL NECROSIS., 10 August 2011 (2011-08-10) | Non-patent | – | – | Search report | – |
98 members in 36 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 62302562 | United States of America | – | |
| 201662302562 | United States of America | P | |
| 2017020529 | United States of America | W |
Members98
| Document | Office | Kind | |
|---|---|---|---|
| US2017252458A1 | United States of America | A1 | |
| CA3013791A1 | Canada | A1 | |
| WO2017151979A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201800110A | Taiwan Province of China | A | |
| AR107787A1 | Argentina | A1 | |
| US2018193478A1 | United States of America | A1 | |
| AU2017225982A1 | Australia | A1 | |
| CO2018008667A2 | Colombia | A2 | |
| SG11201806515RA | Singapore | A | |
| KR20180115330A | Republic of Korea | A | |
| IL261428A | Israel | A | |
| IL261428D0 | Israel | D0 | |
| CN108883198A | China | A | |
| PE20181953A1 | Peru | A1 | |
| CL2018002456A1 | Chile | A1 | |
| EP3423105A1 | European Patent Office (EPO) | A1 | |
| MA45280A | Morocco | A | |
| BR112018067379A2 | Brazil | A2 | |
| MX2018010562A | Mexico | A | |
| PH12018501847A1 | Philippines | A1 | |
| US10322192B2 | United States of America | B2 | |
| JP2019516664A | Japan | A | |
| JP6599019B2 | Japan | B2 | |
| US10548986B2 | United States of America | B2 | |
| JP2020019787A | Japan | A | |
| RU2018134331A | Russian Federation | A | |
| RU2018134331A3 | Russian Federation | A3 | |
| JP2020128413A | Japan | A | |
| US2020297860A1 | United States of America | A1 | |
| SG10202007520WA | Singapore | A | |
| EP3423105B1 | European Patent Office (EPO) | B1 | |
| JP6870051B2 | Japan | B2 | |
| EP3824909A1 | European Patent Office (EPO) | A1 | |
| CL2021000048A1 | Chile | A1 | |
| CL2021000049A1 | Chile | A1 | |
| PT3423105T | Portugal | T | |
| DK3423105T3 | Denmark | T3 | |
| JOP20170053B1 | Jordan | B1 | |
| MA45280B1 | Morocco | B1 | |
| RS62108B1 | Serbia | B1 | |
| RU2754369C2 | Russian Federation | C2 | |
| LT3423105T | Lithuania | T | |
| SMT202100416T1 | San Marino | T1 | |
| HUE054726T2 | Hungary | T2 | |
| HRP20211125T1 | Croatia | T1 | |
| PL3423105T3 | Poland | T3 | |
| MD3423105T2 | Republic of Moldova | T2 | |
| ES2880402T3 | Spain | T3 | |
| JP2021185176A | Japan | A | |
| UA125024C2 | Ukraine | C2 | |
| SI3423105T1 | Slovenia | T1 | |
| MY189113A | Malaysia | A | |
| CN114191428A | China | A | |
| CN114191563A | China | A | |
| CN114272389A | China | A | |
| RU2021125492A | Russian Federation | A | |
| AR121301A2 | Argentina | A2 | |
| AR121302A2 | Argentina | A2 | |
| IL292946A | Israel | A | |
| KR20220101203A | Republic of Korea | A | |
| KR20220101204A | Republic of Korea | A | |
| CY1124628T1 | Cyprus | T1 | |
| TWI772288B | Taiwan Province of China | B | |
| CN108883198B | China | B | |
| KR102445255B1 | Republic of Korea | B1 | |
| KR102456433B1 | Republic of Korea | B1 | |
| TW202241524A | Taiwan Province of China | A | |
| JOP20210073A1 | Jordan | A1 | |
| JOP20210074A1 | Jordan | A1 | |
| JP7254861B2 | Japan | B2 | |
| MX2023003806A | Mexico | A | |
| MX2023003808A | Mexico | A | |
| MX2023003809A | Mexico | A | |
| CN114272389B | China | B | |
| JP2023082096A | Japan | A | |
| PE20231049A1 | Peru | A1 | |
| PE20231050A1 | Peru | A1 | |
| AU2017225982B2 | Australia | B2 | |
| MY199595A | Malaysia | A | |
| TWI825834B | Taiwan Province of China | B | |
| US2023398228A1 | United States of America | A1 | |
| KR20240007722A | Republic of Korea | A | |
| AU2023285804A1 | Australia | A1 | |
| TW202408592A | Taiwan Province of China | A | |
| NZ744808A | New Zealand | A | |
| IL292946B1 | Israel | B1 | |
| KR102702620B1 | Republic of Korea | B1 | |
| CN114191428B | China | B | |
| JP7556086B2 | Japan | B2 | |
| IL292946B2This record | Israel | B2 | |
| JP2024174991A | Japan | A | |
| TWI871094B | Taiwan Province of China | B | |
| NZ785232A | New Zealand | A | |
| IL261428B1 | Israel | B1 | |
| IL320940A | Israel | A | |
| IL261428B2 | Israel | B2 | |
| AU2023285804B2 | Australia | B2 | |
| AU2026201384A1 | Australia | A1 |
Numbers
- Publication
- 292946
- Application
- 292946
Titles2
- English
- ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
- Hebrew
- תצמידי נוגדן–תרופה מבוססי אריבולין ושיטות שימוש
Classification
- CPC, 16
- A61K31/357
- A61K47/6803
- C07K16/30
- C07K16/28
- A61P35/00
- A61K47/65
- A61K47/6849
- C07K16/32
- A61K47/6889
- C07K2317/14
- C07K2317/40
- C07K2317/77
- C07K2317/565
- C07K2317/92
- A61K47/68031
- A61K47/68033
- IPC, 7
- C07K16 28
- A61P35 00
- A61K31 357
- A61K47 68
- A61K47 65
- C07K16 32
- C07K16 30